Clinical Trial Update: A Safety/Tolerability and Pharmakokinetic Study of Sargramostim Administrated in the Gingiva [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetic study of locally administered sargramostim in the gingiva for periodontitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• sargramostim (sargramostim)

Snippet

Sponsor: Innoventus Project AB | Conditions: Periodontitis | Phase 1 | Status: COMPLETED